Viking Global Equities II LP 3 SEC Filings

Filed On	Filing
01 Oct 2021	Form 3: Viking Global Performance Llc, 10% owner and 7 others · Roivant Sciences Ltd Holds 751,766 shares of Common Shares
26 Jun 2019	Form 3: Viking Global Performance Llc, 10% owner and 9 others · Adaptive Biotechnologies Corporation Holds 1,425,000 shares of Common Stock
26 Sep 2018	Form 3: Viking Global Performance Llc, 10% owner and 5 others · Urovant Sciences Ltd. Holds 20,025,098 shares of Common Shares, $0.000037453 par value per share
26 Oct 2016	Form 3: Viking Global Performance Llc, 10% owner and 5 others · Myovant Sciences Ltd. Holds 37,231,342 shares of Common Shares, $0.00001 par value per share
13 Jul 2016	Form 3: Viking Global Performance Llc, 10% owner and 5 others · Sio Gene Therapies Inc. Holds 75,000,000 shares of Common Shares
13 Jul 2016	Form 3: Viking Global Performance Llc, 10% owner and 5 others · Arbutus Biopharma Corp Holds 16,013,540 shares of Common Shares
08 Feb 2016	Form 3: Viking Global Performance Llc, 10% owner and 5 others · Editas Medicine, Inc. Holds 1,020,407 shares of Common Stock
15 Oct 2015	Form 3: Viking Global Investors Lp, 10% owner and 9 others · FIRST DATA CORP
06 Oct 2014	Form 3: Viking Global Equities Lp, 10% owner and 1 other · Wayfair Inc.

Comments